[go: up one dir, main page]

AU2003213662A1 - Mbcats as modifiers of the beta-catenin pathway and methods of use - Google Patents

Mbcats as modifiers of the beta-catenin pathway and methods of use

Info

Publication number
AU2003213662A1
AU2003213662A1 AU2003213662A AU2003213662A AU2003213662A1 AU 2003213662 A1 AU2003213662 A1 AU 2003213662A1 AU 2003213662 A AU2003213662 A AU 2003213662A AU 2003213662 A AU2003213662 A AU 2003213662A AU 2003213662 A1 AU2003213662 A1 AU 2003213662A1
Authority
AU
Australia
Prior art keywords
mbcats
modifiers
beta
methods
catenin pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213662A
Other versions
AU2003213662A8 (en
Inventor
Michael A. Costa
Emery G. Dora Iii
Steven Brian Gendreau
Timothy S. Heuer
Monique Nicoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2003213662A1 publication Critical patent/AU2003213662A1/en
Publication of AU2003213662A8 publication Critical patent/AU2003213662A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/5758—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003213662A 2002-03-01 2003-02-28 Mbcats as modifiers of the beta-catenin pathway and methods of use Abandoned AU2003213662A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36124302P 2002-03-01 2002-03-01
US60/361,243 2002-03-01
PCT/US2003/006359 WO2003074671A2 (en) 2002-03-01 2003-02-28 Mbcats as modifiers of the beta-catenin pathway and methods of use

Publications (2)

Publication Number Publication Date
AU2003213662A1 true AU2003213662A1 (en) 2003-09-16
AU2003213662A8 AU2003213662A8 (en) 2003-09-16

Family

ID=27789097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213662A Abandoned AU2003213662A1 (en) 2002-03-01 2003-02-28 Mbcats as modifiers of the beta-catenin pathway and methods of use

Country Status (2)

Country Link
AU (1) AU2003213662A1 (en)
WO (1) WO2003074671A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001622A (en) * 1995-12-21 1999-12-14 Sunnybrook Health Science Centre Integrin-linked kinase and its use
US6683048B1 (en) * 1997-04-10 2004-01-27 Mcgill University Compounds and methods for stimulating gene expression and cellular differentiation
WO1999057270A2 (en) * 1998-05-01 1999-11-11 Incyte Pharmaceuticals, Inc. Human receptor molecules
AU4834799A (en) * 1998-06-26 2000-01-17 Regents Of The University Of California, The Human az-1 gene, variants thereof and expressed gene products

Also Published As

Publication number Publication date
WO2003074671A3 (en) 2004-05-06
WO2003074671A2 (en) 2003-09-12
AU2003213662A8 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
AU2003213606A1 (en) MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2003248879A1 (en) RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003272400A1 (en) Syts as modifiers of the p21 pathway and methods of use
AU2003251799A1 (en) Mchks as modifiers of the chk1 pathway and methods of use
AU2003295881A1 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003303094A1 (en) MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003299990A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003217851A1 (en) MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
AU2003265263A1 (en) ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003213662A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003295928A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003251826A1 (en) Mp21s as modifiers of the p21 pathway and methods of use
AU2003258095A1 (en) MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003294499A1 (en) Rhebs as modifiers of the rb pathway and methods of use
EP1578945A3 (en) Cct6s as modifiers of the rb pathway and methods of use
AU2003213665A1 (en) Lgals as modifiers of the chk pathway and methods of use
AU2003213693A1 (en) MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
AU2003278811A1 (en) LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003248876A1 (en) MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003215004A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
AU2003223208A1 (en) MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase